ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV

ClinicalTrials.gov ID: NCT02138253

Public ClinicalTrials.gov record NCT02138253. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy

Study identification

NCT ID
NCT02138253
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Conatus Pharmaceuticals Inc.
Industry
Enrollment
64 participants

Conditions and interventions

Interventions

  • IDN-6556 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2014
Primary completion
Feb 14, 2018
Completion
Mar 8, 2018
Last update posted
Dec 10, 2019

2014 – 2018

United States locations

U.S. sites
35
U.S. states
21
U.S. cities
27
Facility City State ZIP Site status
Southern California Research Center Coronado California 92118
Scripps Clinic La Jolla California 92037
Loma Linda University Medical Center Loma Linda California 92354
UCLA Pfleger Liver Institute Los Angeles California 90095
Georgetown University Hospital Washington D.C. District of Columbia 20007
Johns Hopkins Sibley Memorial Hospital Washington D.C. District of Columbia 21287
University of Florida Gainesville Florida 32610
University of Miami Miami Florida 33136
Piedmont Atlanta Hospital Atlanta Georgia 30309
Rush University Medical Center Chicago Illinois 60612
University of Chicago Medicine Chicago Illinois 60637
Indiana University Indianapolis Indiana 46202
University of Kansas Medical Center Kansas City Kansas 66160
University of Louisville Louisville Kentucky 40202
Tulane Health Science Center New Orleans Louisiana 70112
Ochsner Clinic New Orleans Louisiana 70121
John Hopkins Hospital Baltimore Maryland 21287
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Henery Ford Health System Detroit Michigan 48202
Saint Louis University St Louis Missouri 63104
Rutgers New Jersey Medical School Newark New Jersey 07103
Columbia University Medical Center New York New York 10032
University of Cincinnati Physicians Company Cincinnati Ohio 45267
University of Pennsylvania Milton Hershey Hospital Philadelphia Pennsylvania 19104
Temple University Hospital Philadelphia Pennsylvania 19140
Albert Einstein Medical Center Philadelphia Pennsylvania 19141
Baylor All Saints Medical Center Fort Worth Texas 76104
Liver Associates of Texas, PA Houston Texas 77030
University of Texas Health Science Center at Houston Houston Texas 77030
VAMC/Baylor College of Medicine Houston Texas 77030
University of Utah Salt Lake City Utah 84132
Bon Secours Mary Immaculate Hospital Newport News Virginia 23602
Bon Secours St. Mary's Hospital of Richmond Richmond Virginia 23226
McGuire DVAMC Richmond Virginia 23249
University of Washington Harborview Medical Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02138253, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2019 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02138253 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →